Effects of Iloprost on Pulmonary Hemodynamics and Oxygenation in Patients of Chronic Obstructive Pulmonary Disease During One-lung Ventilation
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Iloprost (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 19 Jun 2016 Status changed from recruiting to completed.
- 13 May 2016 The dosage of Iloprost administered to patients was changed from 25 micrograms to 20 micrograms.
- 27 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.